Back to NORGES BANK NORGES BANK

CORTCORT

Showing 6 of 29 quarters

Position history for NORGES BANKNORGES BANK's holdings in Corcept Therapeutics Incorporated.

Yes. Norges Bank holds 487,055 shares of CORT (Corcept Therapeutics), worth $42.3M, as of its Q2 2026 13F filing. It reduced the position by 208,711 shares (-30.0%) from Q4 2025. Norges Bank has held CORT in every 13F on record since Q4 2018, 29 quarterly filings.

Current Value

$42.3M

Current Shares

487,055

Total Value Change

-$16M

Total Shares Change

-772,923

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
487,055
-30.0%
$42.3M0.0%$86.95
0
2025-Q4
Decreased
695,766
-29.1%
$24.2M0.0%$34.80
0
2025-Q2
Increased
981,577
+15.6%
$72M0.0%$73.40
34
2025-Q1
Increased
848,897
+1.7%
$97M0.0%$114.22
30
2024-Q4
Decreased
834,591
-33.8%
$42.1M0.0%$50.39
0
2024-Q3
Increased
1.3M
+53.3%
$58.3M0.0%$46.28
41

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used